Prostate cancer prevention and the VITAL study data

Two sets of data from the 5-year-long VITamin D and OmegA-3 TriaL (VITAL) were published this week in the New England Journal of Medicine. … READ MORE …

Liver disease as an adverse event for men on ADT

A newly published article in the Journal of Urology has indicated risk of an association between treatment with androgen deprivation therapy (ADT) and risk for a spectrum of liver disorders. … READ MORE …